Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Mycobacterium avium complex (MAC) 30S ribosomal subunit is a critical ribonucleoprotein complex essential for bacterial protein synthesis, comprising the 16S ribosomal RNA (rRNA) and various ribosomal proteins (StatPearls, 2023). It functions as the primary site for the initiation of translation and the decoding of genetic information from messenger RNA (mRNA). MAC, which includes species such as M. avium and M. intracellulare, is a major cause of chronic lung disease and disseminated infections, particularly in patients with underlying pulmonary conditions or compromised immune systems (NIH, 2022). This subunit is the specific target for aminoglycoside antibiotics like amikacin, which bind to the A-site of the 16S rRNA to disrupt protein production and induce bacterial cell death (FDA, 2018). Clinical management of MAC is often complicated by the development of resistance, frequently linked to mutations in the rrs gene that encodes the 16S rRNA component of the 30S subunit (Journal of Clinical Microbiology, 2017). Consequently, the 30S subunit remains a focal point for both diagnostic resistance testing and the development of novel antimicrobial agents.
Inhibition of protein synthesis by binding to the A-site of the 16S ribosomal RNA within the 30S subunit, leading to mRNA misreading and inhibition of translocation (Nature, 2014).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mycobacterium avium complex 30S ribosomal subunit (MAC 30S ribosome).